TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PYXS

Pyxis Oncology Inc

Healthcare · Biotechnology

3.40$ +5.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Pyxis Oncology Inc (PYXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 55 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PYXS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
187 174 220 208 195 157 136 123 106 92 64 55
139 125 172 161 149 132 112 100 83 72 46 37
15 9.7 28 25 12 19 13 11 8.9 15 7.2 19
133 119 157 156 145 127 105 89 76 67 42 33
0.0 8.0 3.0 0.7
0.0
2.5
22 24 24 24 24 2.6 2.5 2.5 2.4
49 48 36 39 42 36 33 36 37 38 33 43
28 26 14 17 20 18 14 18 19 21 17 27
1.2 1.2 1.0 1.3 1.4 1.5 1.5 1.6 1.6 1.7 1.8 1.8
3.3 3.9 2.3 5.5 4.9 4.9 2.8 9.4 9.8 11 5.0 3.3
138 126 184 170 154 121 103 88 69 53 31 11
-271 -286 -289 -307 -328 -364 -385 -403 -425 -443 -466 -492
41 45 51 60 61 61 61 62 63 62 63 64

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?